IVVD Invivyd Inc
Price (delayed)
$0.5791
Market cap
$69.47M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.43
Enterprise value
$1.42M
Adagio (Nasdaq: ADGI) is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company’s portfolio of antibodies has
Highlights
The gross profit has soared by 123% from the previous quarter
The revenue has soared by 120% from the previous quarter
The quick ratio has plunged by 68% YoY and by 12% from the previous quarter
Invivyd's equity has plunged by 62% YoY and by 19% from the previous quarter
Key stats
What are the main financial stats of IVVD
Market
Valuations
Earnings
Shares outstanding
119.96M
Market cap
$69.47M
Enterprise value
$1.42M
Price to earnings (P/E)
N/A
Price to book (P/B)
1.03
Price to sales (P/S)
2.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.06
Revenue
$25.38M
Gross profit
$23.77M
Operating income
-$176.88M
Net income
-$169.93M
EBIT
-$169.93M
EBITDA
-$166.81M
Free cash flow
-$170.63M
Per share
Balance sheet
Liquidity
EPS
-$1.43
EPS diluted
-$1.43
Free cash flow per share
-$1.44
Book value per share
$0.56
Revenue per share
$0.21
TBVPS
$1.09
Total assets
$129.52M
Total liabilities
$61.98M
Debt
$1.3M
Equity
$67.54M
Working capital
$38.71M
Debt to equity
0.02
Current ratio
1.62
Quick ratio
1.29
Net debt/EBITDA
0.41
Margins
Efficiency
Dividend
EBITDA margin
-657.2%
Gross margin
93.6%
Net margin
-669.4%
Operating margin
-696.8%
Return on assets
-99.3%
Return on equity
-144.7%
Return on invested capital
N/A
Return on capital employed
-251.6%
Return on sales
-669.4%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
IVVD stock price
How has the Invivyd stock price performed over time
Intraday
7.24%
1 week
-5.91%
1 month
-50.08%
1 year
-84.8%
YTD
30.69%
QTD
-4.33%
Financial performance
How have Invivyd's revenue and profit performed over time
Revenue
$25.38M
Gross profit
$23.77M
Operating income
-$176.88M
Net income
-$169.93M
Gross margin
93.6%
Net margin
-669.4%
The gross profit has soared by 123% from the previous quarter
The revenue has soared by 120% from the previous quarter
IVVD's operating margin has surged by 66% since the previous quarter
Invivyd's net margin has surged by 66% QoQ
Growth
What is Invivyd's growth rate over time
Valuation
What is Invivyd stock price valuation
P/E
N/A
P/B
1.03
P/S
2.7
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.06
IVVD's EPS is up by 27% since the previous quarter and by 21% year-on-year
Invivyd's equity has plunged by 62% YoY and by 19% from the previous quarter
The price to book (P/B) is 36% lower than the last 4 quarters average of 1.5
The revenue has soared by 120% from the previous quarter
Efficiency
How efficient is Invivyd business performance
IVVD's return on equity has dropped by 88% year-on-year but it is up by 7% since the previous quarter
IVVD's return on sales has surged by 66% since the previous quarter
The company's return on assets fell by 46% YoY but it rose by 14% QoQ
Dividends
What is IVVD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for IVVD.
Financial health
How did Invivyd financials performed over time
Invivyd's total assets is 109% more than its total liabilities
The quick ratio has plunged by 68% YoY and by 12% from the previous quarter
IVVD's current ratio has plunged by 64% YoY and by 16% from the previous quarter
Invivyd's debt is 98% lower than its equity
Invivyd's debt to equity has surged by 100% YoY
Invivyd's equity has plunged by 62% YoY and by 19% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.